In recent years, the ratio of ALP to ALB (APAR), as a novel indicator of inflammation and nutritional status, has been shown to be a prognostic biomarker for a variety of diseases, such as cancer and coronary heart disease (16, 17). This evidence concerns the gene ALB and coronary artery disorder.